Hormone therapy

• Health & Medicine

Oestrogen-only HRT after hysterectomy 'may protect against breast cancer'

Women who use oestrogen-only hormone replacement therapy (HRT) to relieve menopausal symptoms after a hysterectomy have a reduced risk of developing or dying from breast cancer. Women who use oestrogen-only hormone replacement therapy (HRT) to relieve menopausal symptoms after a hysterectomy have a reduced risk of developing or dying from breast cancer.

7 March 2012

• Health & Medicine

Cancer Research UK welcomes prostate cancer drug approval in Wales

Cancer Research UK welcomes the news that the All Wales Medicines Strategy Group (AWMSG) has made prostate cancer drug abiraterone available on the NHS, paving the way for NICE to make a positive ruling when they publish their final guidance in May. Cancer Research UK welcomes the news that the All Wales Medicines Strategy Group (AWMSG) has made prostate cancer drug abiraterone available on the NHS, paving the way for NICE to make a positive ruling when they publish their final guidance in May.

20 February 2012

• Health & Medicine

Trial results confirm five years of tamoxifen boosts breast cancer survival

Experts are urging breast cancer patients to complete their full prescription of tamoxifen, following long-term results from a major Cancer Research UK-funded trial which showed the cancer was less likely to come back in women who took the drug for five years, compared to two years. Experts are urging breast cancer patients to complete their full prescription of tamoxifen, following long-term results from a major Cancer Research UK-funded trial which showed the cancer was less likely to come back in women who took the drug for five years, compared to two years.

21 March 2011

• Health & Medicine

Study confirms long-term benefit of anastrozole to stop breast cancer returning

A major international trial has confirmed the long-term benefit of anastrozole to help stop breast cancer coming back or developing in the other breast in postmenopausal women with hormone sensitive early breast cancer, according to a study published in Lancet Oncology today (Wednesday). A major international trial has confirmed the long-term benefit of anastrozole to help stop breast cancer coming back or developing in the other breast in postmenopausal women with hormone sensitive early breast cancer, according to a study published in Lancet Oncology today (Wednesday).

1 December 2010

• Health & Medicine

Radiotherapy cuts deaths from high risk prostate cancer

MEN TREATED with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool MEN TREATED with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool

8 November 2010

• Science & Technology
• Health & Medicine

Treatment reduces dangerous side effects of cancer treatment in children

Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology. Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology.

20 July 2010

• Science & Technology
• Health & Medicine

Scientists unlock key to tamoxifen resistance

Cancer Research UK funded scientists have discovered why some breast cancers are resistant to the commonly used drug tamoxifen, their findings are published in Cancer Research. Cancer Research UK funded scientists have discovered why some breast cancers are resistant to the commonly used drug tamoxifen, their findings are published in Cancer Research.

23 February 2010

• Health & Medicine

Landmark breast cancer trial investigates new technique to predict effectiveness of treatment

The largest clinical trial of its kind - which aims to find out if testing breast cancer cells after two weeks of hormone therapy can help predict how well a woman will respond to treatment - is being outlined at the NCRI Cancer Conference. The largest clinical trial of its kind - which aims to find out if testing breast cancer cells after two weeks of hormone therapy can help predict how well a woman will respond to treatment - is being outlined at the NCRI Cancer Conference.

6 October 2009

• Health & Medicine

HRT increases incidence and deaths from ovarian cancer

Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease, according to a study published in the Lancet. Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease, according to a study published in the Lancet.

19 April 2007

• Health & Medicine

HRT and endometrial cancer - results from the million women study

Some forms of hormone replacement therapy increase the risk of endometrial (womb) cancer, according to results from the Million Women Study, published in the Lancet1today. Some forms of hormone replacement therapy increase the risk of endometrial (womb) cancer, according to results from the Million Women Study, published in the Lancet1today.

28 April 2005

• Health & Medicine

HRT and breast cancer: results of the Million Women study

Some kinds of hormone replacement therapy (HRT) have a much greater effect on a woman's risk of breast cancer than others, according to landmark research published in the Lancet. Some kinds of hormone replacement therapy (HRT) have a much greater effect on a woman's risk of breast cancer than others, according to landmark research published in the Lancet.

7 August 2003

• Health & Medicine

Why women take HRT

A woman's medical history has a greater influence over whether she takes hormone replacement therapy than lifestyle factors or social background, according to a report1 published today. A woman's medical history has a greater influence over whether she takes hormone replacement therapy than lifestyle factors or social background, according to a report1 published today.

11 December 2002